Therapy Protocol
I-131 Radioiodine Therapy – 50 mCi
Intermediate-dose RAI for intermediate-risk thyroid cancer or cases with incomplete remnant ablation.
Dose: 50 mCi
Indication: Thyroid Cancer
Clinical Overview & Mechanism
Intermediate-dose (50 mCi) Radioiodine Therapy is indicated for patients with intermediate-risk differentiated thyroid carcinoma.
Have questions about this therapy?
Book a consultation with Dr. Nikunj Jain for personalized treatment planning and expert guidance.